CV Sciences (CVSI) Interest Coverage Ratio Growth (1y) (2012 - 2026)
CV Sciences (CVSI) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -29,770.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.17% |
| Mar 31, 2026 | -4,793.84% |
| Dec 31, 2025 | 99.82% |
| Sep 30, 2025 | 78.68% |
| Jun 30, 2025 | 89.75% |
| Mar 31, 2025 | 101.93% |
| Dec 31, 2024 | -618,395.95% |
| Sep 30, 2024 | -58.10% |
| Jun 30, 2024 | 37.34% |
| Mar 31, 2024 | -119.68% |
| Mar 31, 2023 | 860.66% |
| Mar 31, 2022 | -61.49% |
| Sep 30, 2021 | -9,485.27% |
| Jun 30, 2021 | -970.74% |
| Mar 31, 2021 | 11.74% |
| Sep 30, 2020 | -930.47% |
| Jun 30, 2020 | -5,980.74% |
| Mar 31, 2020 | -2,410.64% |
| Sep 30, 2019 | -250.70% |
| Jun 30, 2019 | -88.20% |